Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Brooks Automation Inc Market Cap
From what 0 stock analysts predict, the share price for Brooks Automation Inc (BRKS) might decrease by 100% in the next year. This is based on a 12-month average estimation for BRKS. Price targets go from $ to $. The majority of stock analysts believe BRKS is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
About 0 Wall Street analysts have assigned BRKS 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Brooks Automation Inc to perform worse than the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on BRKS. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of BRKS.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
Data Not Found! | ||||
When did it IPO
1995
Staff Count
0
Country
United States
Sector/Industry
/
CEO
Market Cap
$3.59B
In 2023, BRKS generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that BRKS's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Mon, 07 Nov 2022
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Azenta, Inc. (Nasdaq: AZTA) will report its fiscal Q4 and full year 2022 earnings on November 14, 2022, after market close.
Why It Matters - Azenta's upcoming earnings announcement could impact its stock price and investor sentiment, providing insights into the company's financial health and future performance.
Mon, 03 Oct 2022
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Azenta, Inc. has completed its acquisition of B Medical Systems, enhancing its business operations. The transaction was announced previously and is now finalized.
Why It Matters - Azenta's acquisition of B Medical Systems could enhance its market position and expand its product offerings, potentially driving future revenue growth and impacting stock performance.
Tue, 06 Sep 2022
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Azenta, Inc. (Nasdaq: AZTA) will present at the Baird 2022 Global Healthcare Conference in New York City on September 14, 2022, starting at 9:40 am ET.
Why It Matters - Management participation in a major healthcare conference signals potential insights on company strategy and performance, influencing investor sentiment and stock valuation.
Tue, 30 Aug 2022
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Azenta, Inc. (Nasdaq: AZTA) will present at the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, at 4:40 PM ET.
Why It Matters - Azenta's participation in a major healthcare conference signals potential strategic insights and updates, which could influence its stock performance and investor sentiment.
Thu, 11 Aug 2022
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Azenta, Inc. (Nasdaq: AZTA) will participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 16, 2022.
Why It Matters - Azenta's participation in the Needham conference can signal growth potential and innovation in the med tech sector, potentially impacting investor sentiment and stock performance.
Mon, 08 Aug 2022
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Azenta, Inc. (Nasdaq: AZTA) has announced a definitive agreement to acquire B Medical Systems, enhancing its leadership in cold chain solutions and sample management.
Why It Matters - Azenta's acquisition of B Medical Systems strengthens its market position in cold chain solutions, potentially boosting revenue and competitive advantage, impacting stock performance positively.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
